Logo-apb
Adv Pharm Bull. 2021;11(4): 618-623. doi: 10.34172/apb.2021.070
PMID: 34888208        PMCID: PMC8642801

Mini Review

DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment

Mamta Kumari 1 ORCID, Praveen T. Krishnamurthy 1 * ORCID, Sai kiran S. S. Pinduprolu 1, Piyongsola Sola 1

Cited by CrossRef: 2


1- Jiang N, Hu Y, Wang M, Zhao Z, Li M. The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer. BCTT. 2022;Volume 14:291 [Crossref]
2- Marracino L, Fortini F, Bouhamida E, Camponogara F, Severi P, Mazzoni E, Patergnani S, D’Aniello E, Campana R, Pinton P, Martini F, Tognon M, Campo G, Ferrari R, Vieceli Dalla Sega F, Rizzo P. Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach. Front Cell Dev Biol. 2021;9 [Crossref]
3- Yang R, Li Y, Wang H, Qin T, Yin X, Ma X. Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy. Mol Biomed. 2022;3(1) [Crossref]